Почетна › Ulcerativni kolitis › Њујорк › New York City
Kliničke studije za Ulcerativni kolitis u gradu New York City, NY
Jedna studija za Ulcerativni kolitis traži učesnike na lokaciji u gradu New York City ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Тражи се учесникФаза 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Тражи се учесникФаза 2
- Columbia University Medical Center, New York
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Тражи се учесникФаза 3
- New York Gastroenterology Associates ( Site 0253), New York
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Тражи се учесникФаза 3
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)
Тражи се учесникФаза 1/2
- NYU Langone Health, New York
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Тражи се учесникФаза 3
- New York Gastroenterology Associates, New York
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Тражи се учесникФаза 4
- New York Gastroenterology Associates, New York
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Тражи се учесникФаза 2
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Тражи се учесникФаза 2
- Site 037, New York
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Тражи се учесникФаза 2
- Fink Children's Ambulatory Care Center, New York
- Kimmel Pavilion - NYU Langone, New York
- NYU Grossman School of Medicine, New York
- и још 4
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Тражи се учесникОпсервациона студија
- NYU Langone Health, New York
- Lenox Hill Hospital, Northwell Health, New York
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Тражи се учесникФаза 3
- Manhattan Clinical Research, LLC - Site Number: 8400069, New York
- NYU Langone Health - Site Number: 8400091, New York
- Weill Cornell Medical College - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
- и још 2
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Тражи се учесникФаза 2/3
- Columbia University Medical Center, New York
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Тражи се учесникФаза 3
- NYU Langone Health-Site Number: 8400091, New York
- Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
- Lenox Hill Hospital-Site Number: 8400052, New York
- и још 1
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
Тражи се учесникОпсервациона студија
- NYU Langone Health, New York
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Тражи се учесникФаза 3
- New York Presbyterian Hospital, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Тражи се учесникФаза 3
- Icahn School of Medicine at Mount Sinai, New York
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Тражи се учесник
- NYU Langone Health, New York
- Cornell University, New York
BOOM-IBD2 Pivotal Clinical Trial
Тражи се учесник
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Тражи се учесникОпсервациона студија
- New York University, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Тражи се учесникФаза 2
- Mirador Therapeutics Selected Site, New York
Studije za Ulcerativni kolitis u drugim gradovima
- Orlando, FL21 студија
- Miami, FL20 студија
- Houston, TX14 студија
- San Diego, CA13 студија
- Chicago, IL13 студија
- Tacoma, WA13 студија
- St. Louis, MO13 студија
- Tyler, TX13 студија
- San Antonio, TX13 студија
- Colorado Springs, CO12 студија
- Boston, MA12 студија
- Los Angeles, CA11 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.